Cognitive functioning in cancer patients: effect of previous treatment.

Published

Journal Article

Neuropsychological analysis of 47 cancer patients with widely metastatic disease and significant previous treatment indicated that 34% had cognitive deficits. Previous treatment with biologic response modifiers was associated with a 53% frequency of cognitive abnormalities, whereas only 18% of patients who were never treated with biologics had such impairments. The possibility that neurobehavioral abnormalities will result from metastatic disease and treatment regimens is an important factor in determining the risks and benefits of therapy.

Full Text

Duke Authors

Cited Authors

  • Meyers, CA; Abbruzzese, JL

Published Date

  • February 1, 1992

Published In

Volume / Issue

  • 42 / 2

Start / End Page

  • 434 - 436

PubMed ID

  • 1736178

Pubmed Central ID

  • 1736178

Electronic International Standard Serial Number (EISSN)

  • 1526-632X

International Standard Serial Number (ISSN)

  • 0028-3878

Digital Object Identifier (DOI)

  • 10.1212/wnl.42.2.434

Language

  • eng